A007570 Stock Overview
Operates as a pharmaceutical company primarily in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Ilyang Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩10,970.00 |
| 52 Week High | ₩16,080.00 |
| 52 Week Low | ₩9,820.00 |
| Beta | -0.39 |
| 1 Month Change | -2.23% |
| 3 Month Change | -16.51% |
| 1 Year Change | -29.90% |
| 3 Year Change | -60.89% |
| 5 Year Change | -51.57% |
| Change since IPO | 88.62% |
Recent News & Updates
Recent updates
Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?
Apr 04
Should You Be Adding Ilyang PharmaceuticalLtd (KRX:007570) To Your Watchlist Today?
Mar 14Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely
Mar 14Declining Stock and Decent Financials: Is The Market Wrong About Ilyang Pharmaceutical Co.,Ltd (KRX:007570)?
Feb 22Did Business Growth Power Ilyang PharmaceuticalLtd's (KRX:007570) Share Price Gain of 159%?
Feb 01Is Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) Shareholder Ownership Skewed Towards Insiders?
Jan 11
Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly
Dec 24A Look At The Intrinsic Value Of Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
Dec 06Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 18Shareholder Returns
| A007570 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0.09% | 2.3% | -0.5% |
| 1Y | -29.9% | -1.0% | -11.6% |
Return vs Industry: A007570 underperformed the KR Pharmaceuticals industry which returned -1% over the past year.
Return vs Market: A007570 underperformed the KR Market which returned -11.6% over the past year.
Price Volatility
| A007570 volatility | |
|---|---|
| A007570 Average Weekly Movement | 4.0% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A007570 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A007570's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1946 | 637 | Dong-Yeon Kim | www.ilyang.co.kr |
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages.
Ilyang Pharmaceutical Co.,Ltd Fundamentals Summary
| A007570 fundamental statistics | |
|---|---|
| Market cap | ₩202.65b |
| Earnings (TTM) | -₩737.67m |
| Revenue (TTM) | ₩364.56b |
0.5x
P/S Ratio-267.9x
P/E RatioIs A007570 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A007570 income statement (TTM) | |
|---|---|
| Revenue | ₩364.56b |
| Cost of Revenue | ₩168.46b |
| Gross Profit | ₩196.11b |
| Other Expenses | ₩196.84b |
| Earnings | -₩737.67m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -40.95 |
| Gross Margin | 53.79% |
| Net Profit Margin | -0.20% |
| Debt/Equity Ratio | 44.8% |
How did A007570 perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield-365%
Payout RatioDoes A007570 pay a reliable dividends?
See A007570 dividend history and benchmarks| Ilyang PharmaceuticalLtd dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 21 2025 |
| Days until Ex dividend | 0 days |
| Days until Dividend pay date | 115 days |
Does A007570 pay a reliable dividends?
See A007570 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 10:59 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ilyang Pharmaceutical Co.,Ltd is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyung Soo Kim | Cape Investment & Securities Co., Ltd. |
| Jae Hoon Shin | LS Securities Co., Ltd. |
| Jaechul Park | Mirae Asset Securities Co., Ltd. (Pre-Merger) |